BLT’s ‘Your Liver’ Campaign

AMMF is pleased to support the 'Your Liver' campaign, a British Liver Trust campaign in partnership with MediaPlanet UK. Launched on 13th March, with a supplement in The Independent and a dedicated website, the aim of the campaign is to highlight liver diseases and is a good opportunity to raise the awareness of cholangiocarcinoma, one of the least known and poorly understood of the liver diseases. ...

Read More

AMMF at Imperial College 11.02.15

This report on the research presentations and Q&A session at AMMF's event at Imperial College London on 11 February, has been written by Rebecca Morement, who is currently working as an intern with the charity.   A philosophy graduate of the University of York, Rebecca has a keen interest in bioethics, and is gaining a real insight and understanding of the problems associated with cholangio...

Read More

CCF Conference, 5 & 6 February, Salt Lake City, Utah

As part of Cholangiocarcinoma Awareness Month, AMMF's Helen Morement, together with Dr John Bridgewater and Professor Juan Valle from the UK, joined with scientists and clinicians from across the US at The Cholangiocarcinoma Foundation's conference in Salt Lake City, to hear of the progress being made on both sides of the Atlantic towards our shared goal - a cure for cholangiocarcinoma. Amongst the e...

Read More

Cancer52 and Rarer Cancers – Raising the profile

AMMF was represented by Helen Morement at Cancer52's event on 03 March 2015, the aim of which was to raise the profile of the rare and less common cancers at a key time in cancer strategy development ... Speakers included Daniel Ratchford, Chief Executive of Quality Health, Sean Duffy, National Clinical Director for Cancer, and Dawn Green a pseudomyxoma survivor who bravely spoke of her experiences of li...

Read More

Saatchi Bill axed …

The Liberal Democrats have vetoed a proposed law seeking to give doctors legal protection to use innovative treatments on patients when other options have been exhausted.   The Lib Dem Health Minister, Norman Lamb, said he wanted to avoid “the risk of unintended consequences” of Lord Saatchi’s medical innovation bill, which went unopposed in a third reading by the House of Lords and was...

Read More

AMMF at Imperial College London

Information for all attendees at the AMMF event at Imperial College London on Wednesday, 11 February, 2015: If you have requested a place at this event, by now you should have received a confirmation email (as at 9 February)  with venue details, and a copy of the day's programme.  If you haven't received an email, please see below. The final details of the venue and the day's programme are as follows: ...

Read More

February is CC Awareness Month

    During February 2015, AMMF will be redoubling its efforts to raise the awareness of cholangiocarcinoma (CC) throughout the UK and beyond. Throughout the month we will be awareness raising, fundraising and sharing information.  Look out for: • Daily Guest Posts on AMMF's Facebook page. • New information on research AMMF is supporting. • AMMF's exclusive day at Imperia...

Read More

AMMF at the Cancer52 Parliamentary Event

"The hidden majority - improving outcomes for people with rare and less common cancers ..." This was the title of the Cancer52 event, hosted by John Baron MP, Chairman of the All Party Parliamentary Group on Cancer, held in the House of Commons on 10th December 2014. Why "The hidden majority"?  Simply, this describes the shocking fact that 54% of cancer deaths in the UK are attributable to the rarer a...

Read More

AMMF supports Imperial’s CC Biomarker Repository

Following recent discussions, AMMF has now approved a grant of £30,000 to help support the national cholangiocarcinoma biomarker repository at Imperial College London. This funding will help to employ a technician who will log the receipt of existing samples that have already been collected at 8 sites* around the UK, plus new ones as they arrive, register in detail each sample and the patient informat...

Read More

MDT – the CC patient’s perspective

A report on AMMF’s presentation at the ESSO-BASO* Cancer MDT Course, Liverpool, 01 November 2014 By Helen Morement (To view the course programme, click on the image above.) I was invited by Mr Hassan Malik, Consultant Hepatobiliary Surgeon and Clinical Lead at University Hospital, Liverpool to speak to an audience of surgeons at the Cancer MDT Course, on 01 November 2014, on the subject, "MDT -...

Read More